Extension of Comment Period for Proposed Updates to the Bright Futures Periodicity Schedule as Part of the HRSA-Supported Preventive Services Guidelines for Infants, Children, and Adolescents, 57868-57869 [2020-20380]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
57868
Federal Register / Vol. 85, No. 180 / Wednesday, September 16, 2020 / Notices
slide presentations with audio
components to allow the presentation of
materials in a manner that most closely
resembles an in-person advisory
committee meeting.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before October 9, 2020.
Oral presentations from the public will
be scheduled on October 27, 2020,
between approximately 1 p.m. Eastern
Time and 2 p.m. Eastern Time. Those
individuals interested in making formal
oral presentations should notify the
contact person (see FOR FURTHER
INFORMATION CONTACT). The notification
should include a brief statement of the
general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before October
1, 2020. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by October 2, 2020.
For press inquiries, please contact the
Office of Media Affairs at fdaoma@
fda.hhs.gov or 301–796–4540.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact AnnMarie
Williams at Annmarie.Williams@
fda.hhs.gov or 301–796–5966 at least 7
days in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our website at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: September 11, 2020.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2020–20446 Filed 9–15–20; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
18:20 Sep 15, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Extension of Comment Period for
Proposed Updates to the Bright
Futures Periodicity Schedule as Part of
the HRSA-Supported Preventive
Services Guidelines for Infants,
Children, and Adolescents
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
HRSA is providing notice of
a technical issue in the collection of
public comments responding to a
previous Federal Register notice, dated
August 20, 2020, submitted to the
American Academy of Pediatrics
through its publicly available web-based
portal during the period from August
20–27, 2020. After receiving no
comments during this timeframe, a
routine test found that the database that
records public comments was not
connected to the comment form on the
web page. This technical issue has been
resolved and the system is functional
and collecting comments. HRSA
encourages members of the public who
may have previous submitted comments
to resubmit and is extending the time
period for public comments in response
to proposed updates to the Periodicity
Schedule of the Bright Futures
Recommendations for Pediatric
Preventive Health Care (‘‘Bright Futures
Periodicity Schedule’’). The Bright
Futures Periodicity Schedule is part of
the HRSA-supported preventive service
guidelines for infants, children, and
adolescents under, and is maintained, in
part, through a national cooperative
agreement, the Bright Futures Pediatric
Implementation Program.
DATES: The comment period published
in the Federal Register on August 20,
2020, at 85 FR 51454–01 is extended.
Members of the public are invited to
provide written comments no later than
October 16, 2020. All comments
received on or before this date will be
reviewed and considered by the Bright
Futures Periodicity Schedule
Workgroup and provided for further
consideration by HRSA in determining
the recommended updates that it will
support.
ADDRESSES: Members of the public
interested in providing comments can
do so by accessing the public comment
web page at: https://mchb.hrsa.gov/
maternal-child-health-topics/childhealth/bright-futures.html.
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Bethany Miller, HRSA, Maternal and
Child Health Bureau, email: BMiller@
hrsa.gov, telephone: (301) 945–5156.
SUPPLEMENTARY INFORMATION: On August
20, 2020, HRSA published a notice
soliciting public comments regarding
proposed updates to the Bright Futures
Periodicity Schedule (85 FR 51454–01).
Due to technical issues, comments that
may have been submitted between
August 20, 2020, and August 27, 2020,
were not captured. To ensure that all
comments are received and considered,
the public is encouraged to resubmit
any comments that were provided in
response to the notice published on
August 20, 2020 (85 FR 51454–01) and
also is extending the time period for
public comments.
HRSA has funded the Bright Futures
Program as a cooperative agreement
since 1990. A primary focus of this
program is for the funding recipient to
maintain and update the Bright Futures
Guidelines for Health Supervision of
Infants, Children and Adolescents, a set
of materials and tools for providing
quality preventive care screenings and
well-child visits. One component of
these tools is the Bright Futures
Periodicity Schedule, a chart that
identifies the recommended screenings,
assessments, physical examinations,
and procedures to be delivered within
preventive checkups at each age
milestone. Over the program’s existence,
the Bright Futures Periodicity Schedule
has become the accepted schedule
within the United States for preventive
health services through the course of a
child’s development.
Under section 2713 of the Public
Health Service Act, 42 U.S.C. 300gg–13,
non-grandfathered group health plans
and health insurance issuers must
include coverage, without cost sharing,
for certain preventive services, for plan
years (in the individual market, policy
years) that begin on or after the date that
is one year after the date the
recommendation or guideline is issued.
These include preventive health
services provided for in the Bright
Futures Periodicity Schedule as part of
the HRSA-supported Preventive
Services Guidelines for Infants,
Children, and Adolescents. A panel of
pediatric primary care experts convened
to review the latest evidence and
recommends updating the Bright
Futures Periodicity Schedule to include
screening all individuals ages 18 and
older at least once for hepatitis C virus
infection. This proposed update aligns
with the United States Preventive
Services Task Force’s recommendation
that all adults ages 18 to 79 be screened
E:\FR\FM\16SEN1.SGM
16SEN1
Federal Register / Vol. 85, No. 180 / Wednesday, September 16, 2020 / Notices
at least once for hepatitis C virus
infection.
The American Academy of Pediatrics,
which has been the HRSA cooperative
agreement recipient for this program
since 2007, maintains the Periodicity
Schedule. Under HRSA’s cooperative
agreement with the American Academy
of Pediatrics, the Bright Futures
Program is required to administer a
process for developing and regularly
recommending, as needed, updates to
the Bright Futures Periodicity Schedule.
As described in the Notice of Funding
Opportunity for the Bright Futures
Program (HRSA–18–078), the
consideration of potential updates is
expected to be ‘‘a comprehensive,
objective, and transparent review of
available evidence that incorporates
opportunity for public comment.’’
Thomas J. Engels,
Administrator.
[FR Doc. 2020–20380 Filed 9–15–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the National Advisory
Council on Migrant Health
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Secretary’s
National Advisory Council on Migrant
Health (NACMH or Council) has
scheduled a public meeting. Information
about NACMH and the agenda for this
meeting can be found on the NACMH
website at: https://bphc.hrsa.gov/
qualityimprovement/
strategicpartnerships/nacmh.
DATES: October 20–23, 2020; 1:00 p.m.
to 5:00 p.m. Eastern Time (ET).
ADDRESSES: This meeting will be held
by webinar. Instructions for joining the
meetings will be posted on the NACMH
website 30 calendar days before the date
of the meeting. For meeting information
updates, go to the NACMH website at:
https://bphc.hrsa.gov/
qualityimprovement/
strategicpartnerships/nacmh.
FOR FURTHER INFORMATION CONTACT:
Esther Paul, NACMH Designated
Federal Officer (DFO), Strategic
Initiatives and Planning Division, Office
of Policy and Program Development,
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:20 Sep 15, 2020
Jkt 250001
57869
Bureau of Primary Health Care, HRSA,
5600 Fishers Lane, Rockville, Maryland
20857; 301–594–4300; or epaul@
hrsa.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
NACMH
advises, consults with, and makes
recommendations to the Secretary of
HHS on policy, program development,
and other matters of significance
concerning the activities under section
217 of the Public Health Service (PHS)
Act, as amended (42 U.S.C. 218).
Specifically, NACMH provides
recommendations concerning policy
related to the organization, operation,
selection, and funding of migrant health
centers, and other entities under grants
and contracts under section 330 of the
PHS Act (42 U.S.C. 254b). NACMH
meets twice each calendar year, or at the
discretion of the DFO in consultation
with the NACMH Chair.
Since priorities dictate meeting times,
be advised that times and agenda items
are subject to change. The agenda items
for the meeting may include, but are not
limited to, topics and issues related to
migratory and seasonal agricultural
worker health.
Refer to the NACMH website listed
above for all current and updated
information concerning the October
2020 NACMH meeting, including draft
agenda and meeting materials that will
be posted 30 calendar days before the
meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to the NACMH
meeting should be sent to Esther Paul
using the contact information above at
least 5 business days before the meeting.
Individuals who need special
assistance or another reasonable
accommodation should notify Esther
Paul using the contact information
listed above at least 10 business days
before the meeting. All attendees are
required to register to attend the
meeting prior to entry. Instructions for
how to register and join will be posted
on the NACMH website 30 calendar
days before the meeting.
Submission for OMB Review; 30-Day
Comment Request; Bench to Bedside:
Integrating Sex and Gender To
Improve Human Health & Sex as a
Biological Variable: A Primer (Office of
the Director)
SUPPLEMENTARY INFORMATION:
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–20420 Filed 9–15–20; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
National Institutes of Health
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Dr. Chyren
Hunter, Associate Director, Basic and
Translational Research, Office of
Research on Women’s Health, 6707
Democracy Blvd., Room 437, Bethesda,
Maryland 20817 or call non-toll-free
number (301) 496–7849 or email your
request to ORWHCourses@od.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on April 30, 2020, pages
23978–23980 and allowed 60 days for
public comment. One comment was
received. The purpose of this notice is
to allow an additional 30 days for public
comment.
The Office of Research on Women’s
Health, National Institutes of Health
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
ADDRESSES:
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 85, Number 180 (Wednesday, September 16, 2020)]
[Notices]
[Pages 57868-57869]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20380]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Extension of Comment Period for Proposed Updates to the Bright
Futures Periodicity Schedule as Part of the HRSA-Supported Preventive
Services Guidelines for Infants, Children, and Adolescents
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: HRSA is providing notice of a technical issue in the
collection of public comments responding to a previous Federal Register
notice, dated August 20, 2020, submitted to the American Academy of
Pediatrics through its publicly available web-based portal during the
period from August 20-27, 2020. After receiving no comments during this
timeframe, a routine test found that the database that records public
comments was not connected to the comment form on the web page. This
technical issue has been resolved and the system is functional and
collecting comments. HRSA encourages members of the public who may have
previous submitted comments to resubmit and is extending the time
period for public comments in response to proposed updates to the
Periodicity Schedule of the Bright Futures Recommendations for
Pediatric Preventive Health Care (``Bright Futures Periodicity
Schedule''). The Bright Futures Periodicity Schedule is part of the
HRSA-supported preventive service guidelines for infants, children, and
adolescents under, and is maintained, in part, through a national
cooperative agreement, the Bright Futures Pediatric Implementation
Program.
DATES: The comment period published in the Federal Register on August
20, 2020, at 85 FR 51454-01 is extended. Members of the public are
invited to provide written comments no later than October 16, 2020. All
comments received on or before this date will be reviewed and
considered by the Bright Futures Periodicity Schedule Workgroup and
provided for further consideration by HRSA in determining the
recommended updates that it will support.
ADDRESSES: Members of the public interested in providing comments can
do so by accessing the public comment web page at: https://mchb.hrsa.gov/maternal-child-health-topics/child-health/bright-futures.html.
FOR FURTHER INFORMATION CONTACT: Bethany Miller, HRSA, Maternal and
Child Health Bureau, email: [email protected], telephone: (301) 945-
5156.
SUPPLEMENTARY INFORMATION: On August 20, 2020, HRSA published a notice
soliciting public comments regarding proposed updates to the Bright
Futures Periodicity Schedule (85 FR 51454-01). Due to technical issues,
comments that may have been submitted between August 20, 2020, and
August 27, 2020, were not captured. To ensure that all comments are
received and considered, the public is encouraged to resubmit any
comments that were provided in response to the notice published on
August 20, 2020 (85 FR 51454-01) and also is extending the time period
for public comments.
HRSA has funded the Bright Futures Program as a cooperative
agreement since 1990. A primary focus of this program is for the
funding recipient to maintain and update the Bright Futures Guidelines
for Health Supervision of Infants, Children and Adolescents, a set of
materials and tools for providing quality preventive care screenings
and well-child visits. One component of these tools is the Bright
Futures Periodicity Schedule, a chart that identifies the recommended
screenings, assessments, physical examinations, and procedures to be
delivered within preventive checkups at each age milestone. Over the
program's existence, the Bright Futures Periodicity Schedule has become
the accepted schedule within the United States for preventive health
services through the course of a child's development.
Under section 2713 of the Public Health Service Act, 42 U.S.C.
300gg-13, non-grandfathered group health plans and health insurance
issuers must include coverage, without cost sharing, for certain
preventive services, for plan years (in the individual market, policy
years) that begin on or after the date that is one year after the date
the recommendation or guideline is issued. These include preventive
health services provided for in the Bright Futures Periodicity Schedule
as part of the HRSA-supported Preventive Services Guidelines for
Infants, Children, and Adolescents. A panel of pediatric primary care
experts convened to review the latest evidence and recommends updating
the Bright Futures Periodicity Schedule to include screening all
individuals ages 18 and older at least once for hepatitis C virus
infection. This proposed update aligns with the United States
Preventive Services Task Force's recommendation that all adults ages 18
to 79 be screened
[[Page 57869]]
at least once for hepatitis C virus infection.
The American Academy of Pediatrics, which has been the HRSA
cooperative agreement recipient for this program since 2007, maintains
the Periodicity Schedule. Under HRSA's cooperative agreement with the
American Academy of Pediatrics, the Bright Futures Program is required
to administer a process for developing and regularly recommending, as
needed, updates to the Bright Futures Periodicity Schedule. As
described in the Notice of Funding Opportunity for the Bright Futures
Program (HRSA-18-078), the consideration of potential updates is
expected to be ``a comprehensive, objective, and transparent review of
available evidence that incorporates opportunity for public comment.''
Thomas J. Engels,
Administrator.
[FR Doc. 2020-20380 Filed 9-15-20; 8:45 am]
BILLING CODE 4165-15-P
